AXAH.Y heads into its May 7 first-quarter results with a notable split: the ADR pulled back about 2.8% on the week to $47.94, yet borrowing costs have collapsed to their lowest level since at least mid-March, and the wider short positioning picture looks far less charged than it did a month ago.
The clearest story in the lending market is the dramatic easing of borrow costs. Cost to borrow has fallen to just 0.72% annually — down more than 50% over the past month and roughly 20% on the week alone. In early April, when tariff-driven volatility was at its peak, the rate briefly touched 2.22%. That spike has fully unwound. Availability, while not in extreme territory, has tightened somewhat as estimated short interest picked up sharply on April 28, rising 22% in a single day to around 69,000 shares. That daily jump reverses a week of declines and warrants watching, though the overall short score remains a modest 26.9 — placing AXA in the lower third of the short-pressure universe. The FINRA-reported figure of 45,256 shares at the April 15 settlement date provides a useful anchor: the estimated position has been oscillating meaningfully above and below that level, suggesting active short-term positioning rather than a persistent structural short thesis.
Valuation provides a more constructive backdrop. The trailing P/E has drifted to around 9.9x — up roughly 0.6 points over the past month as the share price recovered from the April tariff sell-off, with the ADR gaining nearly 10% on the month despite this week's wobble. Price-to-book remains at 1.75x, broadly flat over 30 days. The dividend score ranks in the 80th percentile, a standout among the factor readings and consistent with AXA's reputation as a steady European income name. EPS momentum scores are softer — 44th percentile on a 30-day basis and 36th on 90 days — which suggests the Street is not expecting a blowout upgrade cycle into the print. The analyst recommendation differential ranks just 7th percentile, meaning consensus skews cautious relative to the broader market. Given that analyst data available on the OTCPK listing is heavily stale, specific price targets have been omitted from this note.
The institutional register tells a fairly stable story. BlackRock holds 6.4% and added a modest 1.3 million shares in the quarter to March 31. Vanguard and T. Rowe Price also added small positions over the same period. The more notable move came from Norges Bank Investment Management, which trimmed its stake by nearly 9.8 million shares as of December 2025 — a meaningful reduction from one of Europe's largest sovereign wealth managers, though it remains a holder at 2.5% of shares. AXA's mutual holding companies, AXA Assurances IARD Mutuelle and AXA Assurances Vie Mutuelle, together control roughly 16% of the register and represent the stable anchor of the shareholder base. Insider data on the OTC listing is stale — the most recent disclosed trade dates to March 2022 — so no conclusions can be drawn from that segment.
The last two earnings prints produced asymmetric outcomes. The February 2026 full-year results delivered a modest +2.7% day-one move, but the stock gave back most of those gains over the subsequent five days, falling 6.6%. The prior event in the data, which recorded a -1.8% immediate reaction, saw a similar pattern of post-result drift lower. The pattern is consistent with a stock where initial relief buying fades as investors digest the detail — a setup worth noting ahead of the May 7 Q1 update, where the read-across from European insurer peers on tariff-related investment portfolio effects will likely dominate the narrative.
The key watch into May 7 is whether the sharp one-day jump in estimated short interest on April 28 represents a genuine rebuild of bearish conviction or simply noise in the thin OTC market — and whether AXA can quantify any tariff-driven drag on its investment portfolio that investors have been pricing in across the broader European insurance sector.
See the live data behind this article on ORTEX.
Open AXAH.Y on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
